In glioma tissues, we found low levels of expression for LINC00641, AL139232.1, and AL691432.4, while high levels of expression were observed for AL390755.1, LEF1-AS1, and LYRM4-AS1 (Fig. S5A-F). Here, LYRM4 is linked to central nervous system cancer.